HomeCompareIMUN vs MO

IMUN vs MO: Dividend Comparison 2026

IMUN yields 2150.54% · MO yields 6.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IMUN wins by $19570427201.52M in total portfolio value
10 years
IMUN
IMUN
● Live price
2150.54%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19570427201.60M
Annual income
$17,930,297,390,180,752.00
Full IMUN calculator →
MO
Altria Group Inc.
● Live price
6.27%
Share price
$67.02
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$28,968.54
Full MO calculator →

Portfolio growth — IMUN vs MO

📍 IMUN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIMUNMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IMUN + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IMUN pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMUN
Annual income on $10K today (after 15% tax)
$182,795.70/yr
After 10yr DRIP, annual income (after tax)
$15,240,752,781,653,638.00/yr
MO
Annual income on $10K today (after 15% tax)
$532.68/yr
After 10yr DRIP, annual income (after tax)
$24,623.26/yr
At 15% tax rate, IMUN beats the other by $15,240,752,781,629,014.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMUN + MO for your $10,000?

IMUN: 50%MO: 50%
100% MO50/50100% IMUN
Portfolio after 10yr
$9785213600.84M
Annual income
$8,965,148,695,104,860.00/yr
Blended yield
91.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

IMUN
No analyst data
Altman Z
-99826.2
Piotroski
3/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-8.6% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMUN buys
0
MO buys
0
No recent congressional trades found for IMUN or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIMUNMO
Forward yield2150.54%6.27%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$19570427201.60M$77.7K
Annual income after 10y$17,930,297,390,180,752.00$28,968.54
Total dividends collected$19454647652.69M$72.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: IMUN vs MO ($10,000, DRIP)

YearIMUN PortfolioIMUN Income/yrMO PortfolioMO Income/yrGap
1← crossover$225,754$215,053.76$10,558$768.31+$215.2KIMUN
2$4,778,865$4,537,308.08$11,352$1,015.87+$4.77MIMUN
3$94,877,803$89,764,417.71$12,482$1,367.86+$94.87MIMUN
4$1,767,079,443$1,665,560,193.96$14,103$1,883.39+$1767.07MIMUN
5$30,882,096,431$28,991,321,427.19$16,472$2,664.91+$30882.08MIMUN
6$506,560,143,158$473,516,299,976.79$20,024$3,897.79+$506560.12MIMUN
7$7,800,995,961,541$7,258,976,608,361.72$25,537$5,933.74+$7800995.94MIMUN
8$112,821,651,087,287$104,474,585,408,437.92$34,478$9,476.77+$112821651.05MIMUN
9$1,532,831,599,456,105$1,412,112,432,792,708.50$49,776$16,022.63+$1532831599.41MIMUN
10$19,570,427,201,598,784$17,930,297,390,180,752.00$77,699$28,968.54+$19570427201.52MIMUN

IMUN vs MO: Complete Analysis 2026

IMUNStock

Immune Therapeutics, Inc. does not have significant operations. The company was formerly known as TNI BioTech, Inc. and changed its name to Immune Therapeutics, Inc. in October 2014. Immune Therapeutics, Inc. is headquartered in Orlando, Florida.

Full IMUN Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this IMUN vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMUN vs SCHDIMUN vs JEPIIMUN vs OIMUN vs KOIMUN vs MAINIMUN vs PMIMUN vs BTIIMUN vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.